Biotech Primer Institute

NIH Recombinant DNA Compliance & Institutional Biosafety Committees

1 STUDENTS ENROLLED

Course Availability: Unlimited views for 72 hours from time of purchase
Course Running Time:
  44 min | Assessment: 20 min
Eligible: .125 American Biological Safety Association Credentialing Maintenance Credits
Course Material: Downloadable PDF of all presented slides
Preview Now: Basics of Institutional Biosafety Committees

NIH Recombinant DNA Compliance & Institutional Biosafety Committees highlights the history and current legislative initiatives for NIH compliance, how these may affect your institution and the operation of the Institutional Biosafety Committee (IBC), expectations of Principal Investigators, awareness of the IBC and its responsibilities, exempt vs. non-exempt experiments, as well as, what to expect during an NIH site visit/audit or facility inspection, and common compliance challenges. It also provides a detailed look at the purpose, composition, responsibilities, and management of IBCs. Requirements set forth by the NIH and other relevant institutions will be covered

What Is Recombinant DNA?
At the end of this section you will be able to:
1. Define recombinant DNA
2. Describe how recombinant DNA is made to make genetically engineered cells
3. Understand how genetically engineered cells are used

History of the NIH Guidelines for Research Involving Recombinant DNA Molecules
At the end of this section you will be able to:
1. Explain why the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) were established
2. How have the NIH Guidelines changed over the past 40 years

Basics of Institutional Biosafety Committees (IBC)
At the end of this section you will be able to:
1. List what is subject to the NIH Guidelines
2. Understand the expectations of the Principal Investigator (PI) and the Institutional Biosafety Committee (IBC) in terms of the NIH Guidelines

Sections of the NIH Guidelines
At the end of this section you will be able to:
1. List what the different appendices cover within the NIH Guidelines

IBC Review of Infectious Agents Protocols
At the end of this section you will be able to:
1. List the types of protocols the IBC is required review
2. List the types of protocols the IBC is not required to review

Site Visits by NIH
At the end of this section you will be able to:
1. Know what the NIH will audit during a site visit
2. List the components of a robust biosafety program

American Biological Safety Association Credentialing Maintenance Credits

FAQ

Continue Learning

Disclaimer

Course Reviews

N.A

ratings
  • 5 stars0
  • 4 stars0
  • 3 stars0
  • 2 stars0
  • 1 stars0

No Reviews found for this course.

BIOTECH PRIMER © 2017